glp 1 agonists anesthesia How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like glp 1 agonists and anesthesia

But one active clinical trial, registered as NCT07092605 on ClinicalTrials.gov, is now specifically studying the effectiveness of microdosed GLP-1 receptor agonists for improving health and quality of life in patients who do not meet traditional prescribing criteria

Winners will pair low price with fast regulatory clearance, device equivalence, and contracted access

In conclusion, while the association between metformin and the incidence of certain cancers remains a subject of debate, metformin exhibits significant protective effects against multiple types of tumors, demonstrating efficacy in inhibiting tumor cell proliferation and progression, reducing cancer risk, and improving cancer-related outcomes [107]

Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, Stewart PM, Nightingale PG, Clarke CE, Rauz S

GLP1 Drugs (Wegovy, Zepbound): Pros: Highly effective, non-invasive, strong appetite suppression, rapid results

Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point